Zobrazeno 1 - 10
of 96
pro vyhledávání: '"G E, Hanks"'
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 43:351-358
To determine the impact of research findings and evolving technology on the patterns of radiotherapy practice for patients with carcinoma of the uterine cervix.Sixty-two radiation therapy facilities participated in the study after having been selecte
Publikováno v:
Journal of Clinical Oncology. 15:230-238
PURPOSE To examine the natural history of patients who have received definitive radiation therapy alone for clinically localized prostate cancer and have an increasing prostate-specific antigen (PSA) profile. PATIENTS AND METHODS One hundred fifty-on
Publikováno v:
The British Journal of Radiology. 69:1165-1170
We describe the application of CT-MRI fusion software for 3D conformal radiotherapy in two patients with localized prostate cancer who had significantly altered pelvic anatomy due to prior surgery. Patient A had a hemipelvectomy for fibrosarcoma and
Autor:
B. E. Epstein, G. E. Hanks
Publikováno v:
CA: A Cancer Journal for Clinicians. 42:223-240
Autor:
T H, Wasserman, T L, Phillips, G E, Hanks, S E, Order, C A, Perez, T F, Pajak, E, Pakuris, L W, Brady, S A, Leibel, J D, Cox
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 20:1383-1391
This paper provides an introduction into the clinical activities of the RTOG (Radiation Therapy Oncology Group), its goals, its organization, its format for protocol development, and presents major areas of achievement. It provides an organizational
Publikováno v:
Cancer. 92(5)
The objective of this study was to determine the effect of dose and its interaction with known prognostic variables, including pretreatment prostate specific antigen (PSA), Gleason score (GS), and T classification, on patients with nonmetastatic pros
Publikováno v:
Journal of behavioral medicine. 24(3)
The purpose of the present study was to systematically compare the psychological and screening profiles of first-degree relatives (FDRs) of prostate cancer patients versus non-FDRs. FDRs (n = 56) and non-FDRs (n = 100), recruited through prostate can
Publikováno v:
Oncology (Williston Park, N.Y.). 15(5)
A study was undertaken to evaluate the question of cure in "young" men with prostate cancer treated by external-beam radiation. Results in young men (or = 65 years) were compared to older men. Biochemical freedom from failure was examined to 10 years
Autor:
R R, Bahnson, G E, Hanks, R P, Huben, P, Kantoff, J M, Kozlowski, M, Kuettel, P H, Lange, C, Logothetis, J M, Pow-Sang, M, Roach, H, Sandler, P T, Scardino, R J, Taylor, D A, Urban, P C, Walsh, T G, Wilson
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities,
Publikováno v:
Cancer. 89(12)
The purpose of this study was to determine the biochemical outcome and factors predictive of outcome in prostate carcinoma patients with Gleason score 7 tumors who were treated with three-dimensional conformal radiation therapy (3DCRT).Between August